<DOC>
	<DOCNO>NCT00713336</DOCNO>
	<brief_summary>This Study compare two ZD4054 ( Zibotentan ) dose ( 10mg 30mg ) placebo positive control look ZD4054 ( Zibotentan ) 's effect ECG Healthy Volunteer</brief_summary>
	<brief_title>Four-period Crossover Study Assess Effects Single Oral Doses ZD4054 ( Zibotentan ) ( 10mg 30mg ) QTc Interval</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Non Smoker Normal rest 12lead ECG normal QTc interval ( &lt; 450 msec ) Negative screen serum hepatitis B surface antigen , hepatitis C antibody Human Immunodeficiency Virus ( HIV ) screen Receipt another new chemical entity 4 month dose study ; participation another study participation noninvasive methodology study drug give within 30 day dose study Risk ( investigator 's opinion ) transmitting , blood body fluid , agent responsible acquire immune deficiency syndrome ( AIDS ) , hepatitis B hepatitis C Judgement investigator , healthy volunteer participate study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>ZD4054</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>QT interval</keyword>
</DOC>